MIP PHARMA DANMARK ApS: Financial statements 2018
CVR: 32886280
Source: annual report 2018, Danish Business Authority
01/07/2017 – 30/06/2018
MIP PHARMA DANMARK ApS (CVR 32886280) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -26,573 and a net result of DKK -34,986 compared with DKK -39,376 the year before. Equity in the 2018 report amounted to DKK -183,799.
- Gross Profit
- DKK -26,573
- Profit/Loss
- DKK -34,986
- Equity
- DKK -183,799
- Total Assets
- DKK 10,764
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -27 t. | -35 t. | -184 t. | 0 |
| 2017 | - | -34 t. | -39 t. | -149 t. | - |
| 2016 | - | -34 t. | -43 t. | -109 t. | - |
| 2015 | - | -42 t. | -47 t. | -67 t. | - |
| 2014 | - | -32 t. | -34 t. | -20 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout MIP PHARMA DANMARK ApS
MIP PHARMA DANMARK ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Jochen Steinhage. The company is owned by MIP Pharma GmbH. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -129,052 and a net result of DKK -155,646 compared with DKK -109,135 the year before. Equity in the 2025 report amounted to DKK -716,683.